June 28, 2025

68Ga-NODAGA-LM3 May Effectively Evaluate Small Cell Lung Cancer Responses – CancerNetwork

June 28, 2025

AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer – Insider Monkey

June 28, 2025

FDA Grants Accelerated Approval to Tarlatamab for Small Cell Lung Cancer Treatment in 2024 – geneonline.com

June 27, 2025

Study points to promising chemoimmunotherapy strategy for aggressive stage III non-small cell lung cancer – Medical Xpress

June 27, 2025

Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway’s lung cancer nod – Fierce Pharma